Lupin Launches Generic Combivir Tablets - equitybulls.com

Pharma major, Lupin Ltd's subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has received final approval for its Lamivudine and Zidovudine Tablets, 150 mg/300 mg. from the United States Food and Drugs Administration (FDA). Lupin has ...

Expect strong growth from US in FY13-14: Lupin - MoneyControl.com

Pharma major Lupin launched an anti-HIV drug Combivir Generic, which is expected to be a limited competition drug for the company. Lupin’s CFO, S Ramesh said the company’s pipeline for the current year and for the coming few years is very ...

Aurobindo Pharma receives final approval for Lamivudine+Zidovudine Tablets - equitybulls.com

Lamivudine & Zidovudine tablets USP 150/300 mg is the generic equivalent of ViiV Healthcare company's Combivir® tablets USP 150/300mg and is indicated as part of antiretroviral (ARV) combination therapy for the treatment of Human ...

Aurobindo Bags USFDA Nod For Lamivudine & Zidovudine Tabs - Top News India

Lamivudine and zidovudine tabs, the generic equivalent of ViiV Healthcare firm's Combivir tabs, are prescribed as part of antiretroviral (ARV) combination therapy for the cure of HIV infected people. The twelve-monthly sale of Lamivudine and zidovudine ...

Aurobindo gets USFDA approval for two tablets - Business Standard

According to APL, the tablets, which are ready for launch, are the generic equivalent of ViiV Healthcare Company's Combivir tablets and are indicated as part of antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV ...

Aurobindo Pharma gets US FDA approval for lamivudine & zidovudine tabs - pharmabiz.com

Lamivudine and zidovudine tablets USP 150/300mg is the generic equivalent of ViiV Healthcare company's Combivir tablets USP 150/300mg and is indicated as part of antiretroviral (ARV) combination therapy for the treatment of human immunodeficiency virus ...

Op-ed: Riding Is Like Choosing to Live - Advocate

My T-cell count was two. And my viral load was off the chart. My doctor immediately put me on a cocktail of Sustiva and Combivir. I spent that next month in the hospital. Five years or so later he changed my cocktail regimen to Atripla ...

Markets drop on rising inflation - rediff.com

Lupin rallied 4.4% to Rs 544 in otherwise weak market in noon deals, on reports that the drug maker is expected to soon launch its generic version of the anti-HIV drug, Combivir, in the United States. The broader markets underperformed the ...

Buy Lupin; target Rs 633: Nirmal Bang - MoneyControl.com

We believe the street’s negative reaction to 4QFY12 results is unwarranted and expect the stock to strongly rebound as multiple near-term triggers - launch of Combivir / Tricor / Oral contraceptives - play out." "Lupin’s 4QFY12 adjusted PAT ...

Indian stocks to watch-May 14 - Reuters

(Economic Times) * Drug maker Lupin Ltd is expected to soon launch its generic version of the anti-HIV drug, Combivir, in the United States. (Business Standard) * Top representatives of various industry bodies and other stakeholders will get a ...